Time filter

Source Type

Clodi M.,ICMR Institute for Cardiovascular and Metabolic Research | Resl M.,ICMR Institute for Cardiovascular and Metabolic Research | Abrahamian H.,Internistisches Zentrum | Foger B.,Interne Abteilung | And 2 more authors.
Wiener Klinische Wochenschrift | Year: 2016

In critical illness hyperglycemia is associated with increased mortality. Based on the currently available evidence, an intravenous insulin therapy should be initiated when blood glucose is above 180 mg/dl. After initiation of insulin therapy blood glucose should be maintained between 140 and 180 mg/dl. © 2016, Springer-Verlag Wien.


Clodi M.,Konventhospital der Barmherzigen Bruder Linz | Clodi M.,ICMR Institute for Cardiovascular and Metabolic Research | Saly C.,Abteilung For Innere Medizin Vivit Institute | Hoppichler F.,Abteilung fur Innere Medizin | And 6 more authors.
Wiener Klinische Wochenschrift | Year: 2016

Diabetes mellitus, cardiovascular disease and heart failure are interacting dynamically. Patients being diagnosed with cardiovascular disease should be screened for diabetes mellitus. Enhanced cardiovascular risk stratification based on biomarkers, symptoms and classical risk factors should be performed in patients with pre-existing diabetes mellitus. © 2016, Springer-Verlag Wien.


Clodi M.,Konventhospital der Barmherzigen Bruder Linz | Clodi M.,ICMR Institute for Cardiovascular and Metabolic Research | Abrahamian H.,Internistisches Zentrum | Drexel H.,Institute for Vascular Investigation and Treatment VIVIT | And 17 more authors.
Wiener Klinische Wochenschrift | Year: 2016

Hyperglycemia significantly contributes to micro- and macrovascular complications in patients with diabetes mellitus. While lifestyle interventions remain cornerstones of disease prevention and treatment, most patients with type 2 diabetes will eventually require pharmacotherapy for glycemic control. The definition of individual targets regarding optimal therapeutic efficacy and safety is of great importance. In this guideline we present the most current evidence-based best clinical practice data for healthcare professionals. © 2016, Springer-Verlag Wien.


PubMed | Internistisches Zentrum, ICMR Institute for Cardiovascular and Metabolic Research, Abteilung fur Innere Medizin and Interne Abteilung
Type: | Journal: Wiener klinische Wochenschrift | Year: 2016

In critical illness hyperglycemia is associated with increased mortality. Based on the currently available evidence, an intravenous insulin therapy should be initiated when blood glucose is above 180 mg/dl. After initiation of insulin therapy blood glucose should be maintained between 140 and 180 mg/dl.

Loading ICMR Institute for Cardiovascular and Metabolic Research collaborators
Loading ICMR Institute for Cardiovascular and Metabolic Research collaborators